Back to results
US 11,229,650 B2Granted
Inhalable imatinib formulations, manufacture, and uses thereof
AssigneeAerovate Therapeutics, Inc.
InventorsBen Dake, Ralph Niven, Andrew D. Levin
Life of this patent
Estimating the term…
Abstract
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Claims14
An inhalable formulation comprising imatinib, wherein greater than 80% of the imatinib in the inhalable formulation is present in a single crystal form.
A method of treating a condition of the pulmonary cardiovascular system, the method comprising providing to a subject an inhalable formulation comprising imatinib, wherein greater than 80% of the imatinib in the inhalable formulation is present in a single crystal form.
Dependencies are inferred from the claim text.